Clinical Trials Logo

Seizures, Epileptic clinical trials

View clinical trials related to Seizures, Epileptic.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02424123 Completed - Epilepsy Clinical Trials

Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults?

SeizS100B
Start date: October 11, 2016
Phase:
Study type: Observational

Seizures represent an important clinical problem, accounting for at least 40% of adult onset epilepsy. Predicting seizure recurrence in subjects experiencing a first seizure is difficult due to the lack of prognostic biomarkers. Recent evidence has indicated that blood-brain barrier (BBB) dysfunction constitutes an etiological factor to seizures. In particular, it has been shown that modification of BBB permeability is associated with seizure activity. In addition, it was demonstrated that BBB permeability can be assessed by measuring serum level of the protein S100B. Based on these data and considerations the investigators will test whether the extent of BBB damage at time of first seizure is predictive for seizure recurrence. The main objective of this study is to evaluate the association between the absolute (ng/ml) serum S100B levels (measured at time of the first seizure) and the experience, or not, of seizure recurrence within one year of follow-up.

NCT ID: NCT00297323 Completed - Seizures, Epileptic Clinical Trials

An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

Start date: June 2005
Phase: N/A
Study type: Observational

The purpose of this observational study is to evaluate the safety of topiramate in adults and children with epilepsy (or seizures) who have not received or have not responded to treatment with previous antiepileptic medication.